Opioid Use Disorder
Nearly three-fourths of the 2.4 million U.S. adults who reported using buprenorphine in 2019 did not misuse the medication in the past 12 months, according to a National Institutes of Health study released in JAMA Network Open.
Strategies for opioid stewardship. This Transformation Talks video explores steps providers can take to help address the opioid crisis.
UChicago Medicine found an opportunity to enhance inpatient treatment for opioid use disorder by leveraging non-specialist clinical expertise and collaborating with local community-based treatment providers. Read more from George Weyer, M.D., about this successful consult service and how it formed.
Access to behavioral health care unfortunately remains difficult due to the shortage of providers, stigma, lack of a true connected continuum of care, and more. This series of case studies featuring the innovative work of hospitals and health systems and their community partners, details how…
This webinar is presented by:
Sarah E. Wakeman, MD
Medical Director, Massachusetts General Hospital Substance Use Disorder Initiative
Medical Director, Massachusetts General Hospital Addiction Consult Team
Director, Addiction Medicine Fellowship Program
Associate Professor of Medicine, Harvard…
About two years ago, the Buprenorphine Team — or B team — was formed at Dell Seton Medical Center in Austin, Texas, in collaboration with Dell Medical School at the University of Texas at Austin. Our goal is to offer Food and Drug Administration (FDA)-approved medications for patients with opioid…
Hospital outpatient departments, critical access hospitals, rural health clinics and other eligible providers may apply through Jan. 3 to participate in the Value in Opioid Use Disorder Treatment demonstration.
The Drug Enforcement Administration published an interim final rule expanding access to medication-assisted treatment under the SUPPORT for Patients and Communities Act of 2018.
Stigma leads to discrimination and creates barriers for people to seek treatment and access care, write Richard Bottner, a physician assistant and affiliate faculty member at Dell Medical School at the University of Texas at Austin, and Rebecca Chickey, AHA’s senior director of Behavioral Health…
In today's episode Elisa Arespacochaga, vice president of AHA's Physician Alliance, sits down with Richard Bottner — an affiliate faculty member at Dell Medical School — to discuss how they have implemented an innovative treatment program to address opioid use disorder and reduce stigma.